Douglas C. Lane & Associates’s Merck MRK Stock Holding History

Douglas C. Lane & Associates’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$27.2M	Sell	539,590 -26,816	-5%	-$1.35M	0.74%	54
2015 Q3	$26.7M	Sell	566,406 -66,588	-11%	-$3.54M	0.76%	48
2015 Q2	$34.4M	Sell	632,994 -95,703	-13%	-$5.37M	0.92%	42
2015 Q1	$40M	Sell	728,697 -169,370	-19%	-$9.59M	1.05%	31
2014 Q4	$48.7M	Sell	898,067 -4,142	-0.5%	-$231K	1.31%	22
2014 Q3	$51M	Sell	902,209 -1,354	-0.1%	-$76K	1.52%	18
2014 Q2	$49.9M	Sell	903,563 -46,255	-5%	-$2.52M	1.51%	17
2014 Q1	$51.5M	Sell	949,818 -16,190	-2%	-$838K	1.65%	12
2013 Q4	$46.1M	Sell	966,008 -54,878	-5%	-$2.51M	1.53%	15
2013 Q3	$46.4M	Buy	1,020,886 +11,735	+1%	+$536K	1.69%	11
2013 Q2	$44.7M	Buy	+1,009,151	New	+$45.1M	1.74%	10

Other funds holding MRK

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Douglas C. Lane & Associates's MRK Position: Q4 2015 in Review

Douglas C. Lane & Associates reduced its Merck (MRK) stake by 4.7% in Q4 2015, selling an estimated $1.35M and leaving 539,590 shares worth $27.2M. The position accounts for 0.74% of the portfolio, ranked #54.

Douglas C. Lane & Associates first reported a position in MRK in Q2 2013 and has held it in 11 quarters since. The position peaked at $51.5M in Q1 2014. 1,755 funds tracked by Wall St. Rank hold MRK as of Q4 2015.

Douglas C. Lane & Associates held 539,590 shares of Merck worth $27.2M as of Q4 2015.
Douglas C. Lane & Associates sold 26,816 Merck shares in Q4 2015, an estimated $1.35M.
Merck made up 0.74% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #54 holding.
Douglas C. Lane & Associates first reported a position in Merck in Q2 2013 and has held it in 11 quarters since.
Douglas C. Lane & Associates's Merck position peaked at $51.5M in Q1 2014.
1,755 funds tracked by Wall St. Rank held Merck as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.